Marathon Trading Investment Management LLC Abb Vie Inc. Transaction History

Marathon Trading Investment Management LLC

  • $201 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$144.61 - $166.54 $144,610 - $166,540
1,000 New
1,000 $159,000
Q4 2022

May 24, 2023
BUY
$138.31 - $165.87 $69,155 - $82,935
500 Added 50.0%
1,500 $242,000
Q4 2021

Feb 11, 2022
BUY
$107.43 - $135.93 $161,145 - $203,895
1,500 New
1,500 $203,000
Q3 2019

Nov 13, 2019
SELL
$62.98 - $75.72 $1.02 Million - $1.23 Million
-16,220 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$65.7 - $83.98 $1.07 Million - $1.36 Million
16,220 New
16,220 $1.18 Million

Others Institutions Holding ABBV

# of Institutions
3,853
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Marathon Trading Investment Management LLC Portfolio

Follow Marathon Trading Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Trading Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Trading Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email